Literature DB >> 16613990

The LIM-homeodomain proteins Isl-1 and Lhx3 act with steroidogenic factor 1 to enhance gonadotrope-specific activity of the gonadotropin-releasing hormone receptor gene promoter.

Anne Granger1, Christian Bleux, Marie-Laure Kottler, Simon J Rhodes, Raymond Counis, Jean-Noël Laverrière.   

Abstract

The GnRH receptor (GnRH-R) plays a central role in mammalian reproductive function throughout adulthood. It also appears as an early marker gene of the presumptive gonadotrope lineage in developing pituitary. Here, using transient transfections combined with DNA/protein interaction assays, we have delineated cis-acting elements within the rat GnRH-R gene promoter that represent targets for the LIM-homeodomain (LIM-HD) proteins, Isl-1 and Lhx3. These factors, critical in early pituitary development, are thus also crucial for gonadotrope-specific expression of the GnRH-R gene. In heterologous cells, the expression of Isl-1 and Lhx3, together with steroidogenic factor 1 (SF-1), culminates in the activation of both the rat as well as human GnRH-R promoter, suggesting that this combination is evolutionarily conserved among mammals. The specificity of these LIM-HD factors is attested by the inefficiency of related proteins, including Lhx5 and Lhx9, to activate the GnRH-R gene promoter, as well as by the repressive capacity of a dominant-negative derivative of Lhx3. Accordingly, targeted deletion of the LIM response element decreases promoter activity. In addition, experiments with Gal4-SF-1 fusion proteins suggest that LIM-HD protein activity in gonadotrope cells is dependent upon SF-1 binding. Finally, using a transgenic model that allows monitoring of in vivo promoter activity, we show that the overlapping expression of Isl-1 and Lhx3 in the developing pituitary correlates with promoter activity. Collectively, these data suggest the occurrence of a specific LIM-HD pituitary code and designate the GnRH-R gene as the first identified transcriptional target of Isl-1 in the anterior pituitary.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16613990     DOI: 10.1210/me.2005-0184

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  27 in total

1.  A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency.

Authors:  Susanne Bechtold-Dalla Pozza; Stefan Hiedl; Julia Roeb; Peter Lohse; Raleigh E Malik; Soyoung Park; Mario Durán-Prado; Simon J Rhodes
Journal:  Horm Res Paediatr       Date:  2012-01-26       Impact factor: 2.852

Review 2.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

3.  ISL1 Is Necessary for Maximal Thyrotrope Response to Hypothyroidism.

Authors:  F Castinetti; M L Brinkmeier; A H Mortensen; K R Vella; P Gergics; T Brue; A N Hollenberg; L Gan; S A Camper
Journal:  Mol Endocrinol       Date:  2015-08-21

4.  Heterozygous LHX3 mutations may lead to a mild phenotype of combined pituitary hormone deficiency.

Authors:  Nicolas Jullien; Pauline Romanet; Mélanie Philippon; Marie-Hélène Quentien; Paolo Beck-Peccoz; Ignacio Bergada; Sylvie Odent; Rachel Reynaud; Anne Barlier; Alexandru Saveanu; Thierry Brue; Frederic Castinetti
Journal:  Eur J Hum Genet       Date:  2018-09-27       Impact factor: 4.246

Review 5.  Roles of the LHX3 and LHX4 LIM-homeodomain factors in pituitary development.

Authors:  Rachel D Mullen; Stephanie C Colvin; Chad S Hunter; Jesse J Savage; Emily C Walvoord; Amrit P S Bhangoo; Svetlana Ten; Johannes Weigel; Roland W Pfäffle; Simon J Rhodes
Journal:  Mol Cell Endocrinol       Date:  2007-01-08       Impact factor: 4.102

6.  Three novel single-nucleotide polymorphisms of the bovine LHX3 gene.

Authors:  Y J Jing; X Y Lan; H Chen; L Z Zhang; C L Zhang; C Y Pan; M J Li; G Ren; T B Wei; M Zhao
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

7.  The LIM homeodomain transcription factor LHX6: a transcriptional repressor that interacts with pituitary homeobox 2 (PITX2) to regulate odontogenesis.

Authors:  Zichao Zhang; Diana Gutierrez; Xiao Li; Felicitas Bidlack; Huojun Cao; Jianbo Wang; Kelsey Andrade; Henry C Margolis; Brad A Amendt
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

8.  Implementing the LIM code: the structural basis for cell type-specific assembly of LIM-homeodomain complexes.

Authors:  Mugdha Bhati; Christopher Lee; Amy L Nancarrow; Mihwa Lee; Vanessa J Craig; Ingolf Bach; J Mitchell Guss; Joel P Mackay; Jacqueline M Matthews
Journal:  EMBO J       Date:  2008-06-26       Impact factor: 11.598

9.  Developmental analysis and influence of genetic background on the Lhx3 W227ter mouse model of combined pituitary hormone deficiency disease.

Authors:  Kelly L Prince; Stephanie C Colvin; Soyoung Park; Xianyin Lai; Frank A Witzmann; Simon J Rhodes
Journal:  Endocrinology       Date:  2013-01-03       Impact factor: 4.736

10.  GATA2-induced silencing and LIM-homeodomain protein-induced activation are mediated by a bi-functional response element in the rat GnRH receptor gene.

Authors:  Anne-Laure Schang; Anne Granger; Bruno Quérat; Christian Bleux; Joëlle Cohen-Tannoudji; Jean-Noël Laverrière
Journal:  Mol Endocrinol       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.